Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-02-04

Clinical Trial Update: Assessment of St Jude Medical Portico Re-sheathable Transapical Aortic Valve System [NA]

View source ↗

Summary

A clinical trial evaluating the Portico Re-sheathable Transapical Aortic Valve System sponsored by Abbott has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Portico Re-sheathable Transapical Aortic Valve System

Snippet

Sponsor: Abbott Medical Devices | Conditions: Severe Symptomatic Aortic Stenosis | NA | Status: WITHDRAWN